Skip to main content
Watch Insiders

Institutional filer profile

Fairmount Funds Management LLC Insider Trades

Latest reported as Corporate insider of CRESCENT BIOPHARMA, INC. (CBIO).

Purchase filings
2
Reported companies
4
Net open-market value
-$667,298,058.41
Latest transaction
Jul 16, 2026

Affiliated corporations

Reported company relationships

CBIOLatest reported

CRESCENT BIOPHARMA, INC.

Corporate insider

ORKAPrior filing

Oruka Therapeutics, Inc.

Corporate insider

SYREPrior filing

Spyre Therapeutics, Inc.

Corporate insider

VRDNPrior filing

Viridian Therapeutics, Inc.\DE

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 16, 2026CRESCENT BIOPHARMA, INC. (CBIO)Corporate insiderOpen Market Purchase853,450$14.50$12,375,025
Jul 1, 2026Oruka Therapeutics, Inc. (ORKA)Corporate insiderSale3,553,410$84.43$300,014,406
Jun 23, 2026Spyre Therapeutics, Inc. (SYRE)Corporate insiderSale4,684,781$85.31$399,658,667
May 11, 2026Viridian Therapeutics, Inc.\DE (VRDN)Corporate insiderOpen Market Purchase1,176,470$17.00$19,999,990